AstraZeneca in June picked Emergent to help produce 300 million doses of its potential COVID-19 vaccine pledged to the United States. AstraZeneca has signed manufacturing deals globally to meet its target of making 2 billion doses of the vaccine, including with two Bill Gates-backed ventures and a $1.2 billion agreement with the U.S. government. The latest contract follows an $87 million contract in June where Emergent signed an agreement to become the development partner for AstraZeneca’s COVID-19 vaccine candidate. …read more
Source:: Yahoo Finance
